Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
作者信息
Bahl Kapil, Senn Joe J, Yuzhakov Olga, Bulychev Alex, Brito Luis A, Hassett Kimberly J, Laska Michael E, Smith Mike, Almarsson Örn, Thompson James, Ribeiro Amilcar Mick, Watson Mike, Zaks Tal, Ciaramella Giuseppe
出版信息
Mol Ther. 2022 Aug 3;30(8):2874. doi: 10.1016/j.ymthe.2022.07.013. Epub 2022 Aug 2.
Abstract
摘要
相似文献
1
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
Mol Ther. 2022 Aug 3;30(8):2874. doi: 10.1016/j.ymthe.2022.07.013. Epub 2022 Aug 2.
2
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials.
Vaccine. 2019 May 31;37(25):3326-3334. doi: 10.1016/j.vaccine.2019.04.074. Epub 2019 May 10.
3
PB2-588 V promotes the mammalian adaptation of H10N8, H7N9 and H9N2 avian influenza viruses.
Sci Rep. 2016 Jan 19;6:19474. doi: 10.1038/srep19474.
4
Structural basis for preferential avian receptor binding by the human-infecting H10N8 avian influenza virus.
Nat Commun. 2015 Jan 9;6:5600. doi: 10.1038/ncomms6600.
5
[A report of first fatal case of H10N8 avian influenza virus pneumonia in the world].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Feb;26(2):120-2. doi: 10.3760/cma.j.issn.2095-4352.2014.02.013.
6
Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
J Virol. 2015 Oct 28;90(2):851-61. doi: 10.1128/JVI.02275-15. Print 2016 Jan 15.
7
Antibodies against H10N8 avian influenza virus among animal workers in Guangdong Province before November 30, 2013, when the first human H10N8 case was recognized.
BMC Med. 2014 Oct 27;12:205. doi: 10.1186/s12916-014-0205-3.
8
The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
Vaccine. 2019 Nov 8;37(47):7117-7122. doi: 10.1016/j.vaccine.2019.03.024. Epub 2019 Aug 2.
9
Phylogenetic Analysis and Pathogenicity Assessment of Two Strains of Avian Influenza Virus Subtype H9N2 Isolated from Migratory Birds: High Homology of Internal Genes with Human H10N8 Virus.
Front Microbiol. 2016 Feb 29;7:57. doi: 10.3389/fmicb.2016.00057. eCollection 2016.
10
Emergence in China of human disease due to avian influenza A(H10N8)--cause for concern?
J Infect. 2014 Mar;68(3):205-15. doi: 10.1016/j.jinf.2013.12.014. Epub 2014 Jan 6.
引用本文的文献
1
Lipid nanoparticles-mRNA based on the consensus sequences of avian coronavirus S1 and N genes protect animals against multiple viral infections.
J Nanobiotechnology. 2025 Aug 30;23(1):595. doi: 10.1186/s12951-025-03668-5.
2
Review on the bioanalysis of non-virus-based gene therapeutics.
Bioanalysis. 2024 Dec-Dec;16(23-24):1279-1294. doi: 10.1080/17576180.2024.2437418. Epub 2024 Dec 14.
3
Nucleic acid drugs: recent progress and future perspectives.
Signal Transduct Target Ther. 2024 Nov 29;9(1):316. doi: 10.1038/s41392-024-02035-4.
4
mRNA therapeutics: New vaccination and beyond.
Fundam Res. 2023 Mar 16;3(5):749-759. doi: 10.1016/j.fmre.2023.02.022. eCollection 2023 Sep.
5
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses.
NPJ Vaccines. 2023 Sep 7;8(1):132. doi: 10.1038/s41541-023-00728-5.
6
Hemagglutinin expressed by yeast reshapes immune microenvironment and gut microbiota to trigger diverse anti-infection response in infected birds.
Front Immunol. 2023 Apr 18;14:1125190. doi: 10.3389/fimmu.2023.1125190. eCollection 2023.
Zotero 插件